TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data

Shares of Titan Pharmaceuticals Inc. (TTNP) were up over 20% in extended trading on Thursday, following FDA approval of Probuphine implant for the treatment of opioid dependence.

from RTT - Biotech http://ift.tt/1TZD2C4
via IFTTT